Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
3
33%
Ph phase_3
2
22%
Ph phase_4
1
11%
Ph not_applicable
2
22%
Ph phase_1
1
11%

Phase Distribution

4

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
3(33.3%)
Phase 1Safety & dosage
1(11.1%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting3
Completed3
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (33.3%)
Phase 11 (11.1%)
Phase 32 (22.2%)
Phase 41 (11.1%)
N/A2 (22.2%)

Trials by Status

recruiting111%
not_yet_recruiting333%
unknown111%
withdrawn111%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9